Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

400 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Minimization of curative surgery for treatment of early cervical cancer: a review.
Arimoto T, Kawana K, Adachi K, Ikeda Y, Nagasaka K, Tsuruga T, Yamashita A, Oda K, Ishikawa M, Kasamatsu T, Onda T, Konishi I, Yoshikawa H, Yaegashi N; Gynecologic Cancer Study Group of the Japan Clinical Oncology Group. Arimoto T, et al. Among authors: kasamatsu t. Jpn J Clin Oncol. 2015 Jul;45(7):611-6. doi: 10.1093/jjco/hyv048. Epub 2015 Apr 16. Jpn J Clin Oncol. 2015. PMID: 25888708 Review.
Non-randomized confirmatory trial of modified radical hysterectomy for patients with tumor diameter 2 cm or less FIGO Stage IB1 uterine cervical cancer: Japan Clinical Oncology Group Study (JCOG1101).
Kunieda F, Kasamatsu T, Arimoto T, Onda T, Toita T, Shibata T, Fukuda H, Kamura T; Gynecologic Cancer Study Group of the Japan Clinical Oncology Group. Kunieda F, et al. Among authors: kasamatsu t. Jpn J Clin Oncol. 2015 Jan;45(1):123-6. doi: 10.1093/jjco/hyu168. Epub 2014 Nov 2. Jpn J Clin Oncol. 2015. PMID: 25368103 Clinical Trial.
Clinical tumor diameter and prognosis of patients with FIGO stage IB1 cervical cancer (JCOG0806-A).
Kato T, Takashima A, Kasamatsu T, Nakamura K, Mizusawa J, Nakanishi T, Takeshima N, Kamiura S, Onda T, Sumi T, Takano M, Nakai H, Saito T, Fujiwara K, Yokoyama M, Itamochi H, Takehara K, Yokota H, Mizunoe T, Takeda S, Sonoda K, Shiozawa T, Kawabata T, Honma S, Fukuda H, Yaegashi N, Yoshikawa H, Konishi I, Kamura T; Gynecologic Oncology Study Group of the Japan Clinical Oncology Group. Kato T, et al. Among authors: kasamatsu t. Gynecol Oncol. 2015 Apr;137(1):34-9. doi: 10.1016/j.ygyno.2015.01.548. Epub 2015 Feb 7. Gynecol Oncol. 2015. PMID: 25662625
Combination of squamous cell carcinoma-antigen, carcinoembryonic antigen, and carbohydrate antigen 19-9 predicts positive pelvic lymph nodes and parametrial involvement in early stage squamous cell carcinoma of the uterine cervix.
Ikeda S, Yoshimura K, Onda T, Kasamatsu T, Kato T, Ishikawa M, Sasajima Y, Tsuda H. Ikeda S, et al. Among authors: kasamatsu t. J Obstet Gynaecol Res. 2012 Oct;38(10):1260-5. doi: 10.1111/j.1447-0756.2012.01862.x. Epub 2012 May 8. J Obstet Gynaecol Res. 2012. PMID: 22563932
Status of treatment for the overall population of patients with stage IVb endometrial cancer, and evaluation of the role of preoperative chemotherapy: a retrospective multi-institutional study of 426 patients in Japan.
Eto T, Saito T, Shimokawa M, Hatae M, Takeshima N, Kobayashi H, Kasamatsu T, Yoshikawa H, Kamura T, Konishi I. Eto T, et al. Among authors: kasamatsu t. Gynecol Oncol. 2013 Dec;131(3):574-80. doi: 10.1016/j.ygyno.2013.08.036. Epub 2013 Sep 7. Gynecol Oncol. 2013. PMID: 24016406
Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study.
Ishikawa M, Kasamatsu T, Tsuda H, Fukunaga M, Sakamoto A, Kaku T, Nakanishi T, Hasumi Y, Iwata T, Baba T, Nogawa T, Kudaka W, Kaneda H, Ono S, Saito F, Taniguchi Y, Okada S, Mizuno M, Onda T, Yaegashi N. Ishikawa M, et al. Among authors: kasamatsu t. Gynecol Oncol. 2018 Jan;148(1):139-146. doi: 10.1016/j.ygyno.2017.10.027. Epub 2017 Nov 4. Gynecol Oncol. 2018. PMID: 29113721
400 results